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Abstract
Background: Aryl hydrocarbon receptor (AhR), a transcription factor of the bHLH/PAS family, is well characterized to
regulate the biochemical and toxic effects of environmental chemicals. More recently, AhR activation has been shown to
regulate the differentiation of Foxp3
+ Tregs as well as Th17 cells. However, the precise mechanisms are unclear. In the
current study, we investigated the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent AhR ligand, on epigenetic
regulation leading to altered Treg/Th17 differentiation, and consequent suppression of colitis.
Methodology/Principal Findings: Dextran sodium sulphate (DSS) administration induced acute colitis in C57BL/6 mice, as
shown by significant weight loss, shortening of colon, mucosal ulceration, and increased presence of CXCR3
+ T cells as well
as inflammatory cytokines. Interestingly, a single dose of TCDD (25 mg/kg body weight) was able to attenuate all of the
clinical and inflammatory markers of colitis. Analysis of T cells in the lamina propria (LP) and mesenteric lymph nodes (MLN),
during colitis, revealed decreased presence of Tregs and increased induction of Th17 cells, which was reversed following
TCDD treatment. Activation of T cells from AhR
+/+ but not AhR
-/- mice, in the presence of TCDD, promoted increased
differentiation of Tregs while inhibiting Th17 cells. Analysis of MLN or LP cells during colitis revealed increased methylation
of CpG islands of Foxp3 and demethylation of IL-17 promoters, which was reversed following TCDD treatment.
Conclusions/Significance: These studies demonstrate for the first time that AhR activation promotes epigenetic regulation
thereby influencing reciprocal differentiation of Tregs and Th17 cells, and amelioration of inflammation.
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Introduction
Aryl hydrocarbon receptor (AhR) is a transcription factor that
resides in the cytosol, and is a member of the bHLH-PAS protein
family [1,2]. Activation of AhR leads to conformational change and
translocation to the nucleus where it binds to its dimerization partner,
aryl hydrocarbon receptor nuclear translocator (ARNT). The AhR-
ARNT complex initiates transcription of genes with promoters
containing a dioxin-responsive element (DRE) consensus sequence.
Wide range chemicals can activate AhR including environmental
contaminants such as 2,3,7,8-Tetrachlorodibenzodioxin (TCDD),
and other compounds such as tryptophan derivatives, flavonoids and
biphenyls [3]. AhR was first discovered and well characterized as a
transcription factor responsible for the activation of genes encoding a
number ofxenobiotic metabolizing enzymes, and mediatethetoxicity
induced by TCDD [4]. Interestingly, recent studies indicated that
AhR activation plays diverse roles in cellular functions, including the
regulation of the immune system [5,6].
Recently, the role of AhR activation in the regulation of T cell
differentiation has generated significant interest [7,8]. AhR was
shown to be express by both Th17 and Tregs, and furthermore,
AhR activation promoted their differentiation [9,10]. The
development of Tregs and Th17 cells is reciprocally regulated.
Thus, while transforming growth factor (TGF)-b1 induces the
differentiation of Treg cells [11], the TGF-b1 along with
combination of IL-6 or IL-21 results in the differentiation of
Th17 [12,13]. Thus, it is not clear how AhR activation leads to the
induction of both Tregs and Th17 cells. One possibility is that the
type of ligand and its affinity to AhR may determine whether
Th17 or Tregs are induced [14]. Moreover, previous studies from
our laboratory have shown that activation of AhR by TCDD
induces up-regulation of Fas and Fas ligand, thereby promoting
activation-induced cell death [15,16,17]. Thus, in vivo these events
are also likely to skew the T cell differentiation. The impact of such
factors on T cell differentiation, in vivo has not been taken into
consideration.
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and ulcerative colitis (UC), are syndromes characterized by
chronic inflammation in gastrointestinal tract. Currently it is
believed that persistent intestinal inflammation may be the result
of a dysregulated immune response to commensal enteric bacterial
antigens [18,19]. The chronic nature of inflammation appears to
be a polarized dysregulated immune response due to imbalance of
immune homeostasis involving Th1, Th17, and/or Th2 cells
[20,21,22,23]. In addition, specialized population of regulatory T
cells (Tregs) that express forkhead transcription factor (Foxp3) play
an important role in the control of intestinal inflammation [24].
The naturally arising CD4
+ CD25
+ Tregs have been shown to
prevent or even cure colitis in the T cell transfer model [25,26].
Also, mutations in Foxp3 results in fatal immune disorder
characterized by an uncontrolled T cell proliferation, and
drastically elevated production of Th1 and Th2 cytokines
suggesting the critical role played by Tregs in immune system
homeostasis [27].
Oral consumption of DSS triggers colitis in mice that is similar
in the expression profiles of cytokines as well as histological
changes as those observed in human IBD, particularly UC [28].
Recent studies indicated that during acute DSS-induced colitis,
there was induction in Th1 and Th17 cytokine profiles and that
this converted into a Th2-biased (IL-4 and IL-10) inflammatory
profile during the chronic stages of colitis [28,29]. Mice deficient
in IL-17A gene, showed only faint manifestations of colitis thereby
suggesting that IL-17A plays a pivotal role in the pathogenesis of
DSS-induced colitis [30]. In the current study, we used TCDD to
activate the AhR and determine the reciprocal regulation of Th17
and Treg differentiation during DSS-induced colitis. We noted
that TCDD ameliorated colitis by up-regulating Tregs and down-
regulating Th17 cells through epigenetic regulation.
Results
Effect of AhR activation on DSS-induced colitis
Acute colitis was induced by using dextran sulfate sodium (DSS)
as described elsewhere [31]. In brief, 8-week-old C57BL/6 mice
received either drinking water or water containing 3% DSS (MP
Biomedicals, LLC, Aurora, OH) (ad libitum) for 7 days followed
by water cycle alone for 7 days. The body weight of mice was
monitored every day from day 0, at the start of TCDD treatment.
Mice received a single dose of 25 mg/kg body weight of TCDD
dissolved in corn oil or corn oil alone as a vehicle control.
Throughout the study, we used 4 groups of mice: Vehicle alone,
TCDD alone, DSS+vehicle and DSS+TCDD.
DSS administration induced acute colitis in C57BL/6 mice, as
shown by significant weight loss, shortening of colon, mucosal
ulceration and increased inflammatory cytokine production. DSS-
induced colitis caused significant reduction in the body weight,
which continued to decline throughout the study (Fig 1A).
Interestingly, a single dose of TCDD was able to reverse the
course of the disease beginning day 9. Throughout the study, mice
receiving TCDD alone showed no significant alterations in the
various parameters such as inflammation score and inflammatory
cytokines when compared to vehicle-treated mice. Thus, we have
primarily focused our discussion below, on results comparing
DSS+vehicle versus DSS+TCDD groups.
AhR activation attenuates the severity of colitis
The colitis-induced mice that received TCDD had significant
reductions in intestinal inflammation (Fig 1B). The mean
histological scores in DSS+vehicle groups were significantly higher
than the scores in mice treated with DSS+TCDD (Fig 1C). The
pathologic changes associated with colitis included epithelial
disruption, transmural necrosis, edema, and diffuse leukocyte
infiltrates (polymorphonuclear leukocytes, lymphocytes and eosin-
ophils) in the colon. The architecture of the crypts was distorted
and the lamina propria was thickened in the area of distorted
crypts. Most importantly, the number of inflammatory infiltrates
was significantly reduced after TCDD treatment (Fig. 1B).
AhR activation decreases the induction of serum
inflammatory cytokine/chemokines associated with
colitis
TNF-a, IFN-c, MCP-1, IL-17, KC and Eotaxin-1 have been
shown to be over-produced during inflammatory diseases,
including IBD or in experimental model of colitis [32,33,34].
We therefore determined if TCDD treatment in DSS-induced
colitis, would lead to decreased systemic levels of these cytokines
and chemokines. DSS significantly increased these pro-inflamma-
tory cytokines/ chemokines during acute colitis. In contrast,
TCDD treatment decreased IL-17, IFN-c, MCP-1, TNF-a,K C
and eotaxin-1 levels in the serum of mice with acute colitis (Fig.
S1).
AhR activation reduces both mucosal and systemic CD4
+
CXCR3
+ T cells after colitis
The association between CXCR3 expression and Th1-depen-
dent immunity has been observed in several models of inflamma-
tory diseases. Previously we have shown that blockade of CXCR3
ligands abrogated spontaneous colitis in IL-10
-/- mice [35]. To
examine whether TCDD differentially affected the T effector
population that express CXCR3, splenic, MLN and LP cells were
analyzed. We found a significant increase in the percentage of
splenic, MLN and LP CD4
+T cells that expressed CXCR3
+
during DSS induced colitis (Fig. 2A–B), which was reversed
following TCDD treatment. Moreover, the absolute number of
CXCR3
+ T cells in Spleen, MLN and LP rose significantly in
DSS+vehicle groups and decreased following TCDD treatment
(Fig. 2A–B).
AhR activation triggers Treg cells during colitis
Previous studies have provided convincing evidence that Tregs
play an important role in the control of intestinal inflammation
[24]. Also, based on the previous report that AhR activation leads
to Treg differentiation in a ligand-specific fashion [14], we next
determined whether TCDD induces Tregs in DSS-induced colitis.
We analyzed Tregs in the MLN and LP by flow cytometry after
TCDD treatment. We noted a significant increase in the
percentage and absolute numbers of Tregs in the LP in
DSS+TCDD group when compared to DSS+vehicle group
(Fig. 2C–D). Although a similar trend was seen in the MLN, it
was not statistically significant. Also, TCDD treatment alone
caused a modest increase in Tregs in both MLN and LPL when
compared to vehicle controls.
Effect of AhR activation on Foxp3 and IL-17 expression in
lymphoid organs during DSS-induced colitis
Because of the low recovery of cells from LP, and the low
frequency of Tregs and Th17 cells in the LP and MLN, we
performed RT-PCR to further characterize the effect of AhR
activation during colitis on induction of Tregs and IL-17. We
noted a significant down-regulation of FoxP3 and upregulation of
IL-17 in DSS+vehicle groups when compared to vehicle-treated
normal mice (Fig. 3A–B). Following TCDD treatment of colitis
(DSS+TCDD), this trend was reversed (Fig. 3A–B). We also noted
AhR Activation Attenuates Colonic Inflammation
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upregulation in Foxp3 expression while IL-17 levels showed no
significant change, when compared to vehicle treated normal
mice. The constitutive IL-17 expression in LPL in normal control
mice may result from the activation of these cells by the gut flora.
Effect of TCDD and FICZ in the differentiation of Tregs
and Th17 cells in vitro
To further address the effect of AhR activation on Treg and
Th17 differentiation, we performed a series of in vitro studies. T
cells obtained from normal mouse MLN were activated with anti-
CD3+CD28 mAbs, and treated with vehicle or TCDD. The
analysis of T cells differentiation revealed that TCDD caused
dramatic induction of Tregs (,20.4%) when compared to vehicle
controls (,4.5%) (Fig. 4A). However, these culture conditions did
not favor the induction of Th17 cells (Fig. 4B). Similarly, when we
examined generation of Tregs and Th17 cells in Ova antigen-
specific activated T cells from OT.II.2a mice, in the presence or
absence of TCDD, we observed significantly higher number, and
percentage of Tregs (,19.3% CD4
+Foxp3
+ cells) in the presence
of TCDD when compared to vehicle (,7.8%; Fig 4C). However,
these culture conditions also failed to yield significant induction of
Th17 cells (Fig. 4D).
Because the culture conditions to activate T cells did not
generate significant levels of Th17 cells, next we used bone
marrow-derived dendritic cells (BMDCs), lower dose (0.5 mg/ml))
of anti-CD3 Abs, and pertusis toxin (PTX), which together is
known to promote Th17 cells differentiation in vitro [36] and then
tested the effect of TCDD. We also used FICZ, another AhR
ligand that has been shown to promote the generation of Th17
cells but not Tregs [14]. In the presence of vehicle alone, low levels
of Th17 and Tregs were generated (Fig 4E–F). However, in the
presence of TCDD, there was marked induction of Tregs but not
Th17 cells (Fig 4E–F). Addition of PTX to cultures lowered the
generation of Tregs (Fig 4E) but increased the generation of IL-17
+
cells (Fig 4F). Interestingly, in the presence of PTX+TCDD,
differentiation of Tregs was significantly higher than in cultures
with PTX alone (Fig 4E). Also, while PTX alone promoted the
strong differentiation of Th17 cells, PTX+TCDD group had
significantly lower percentage and numbers of Th17 cells (Fig 4F).
Addition of FICZ to cultures did not cause much change in Tregs
in the presence or absence of PTX (Fig 4E). However, FICZ alone
Figure 1. Change in body weight, histological characterization, and severity of colitis in mice after DSS induction and TCDD
treatment. A. We used 4 groups of C57BL/6 mice: those that received VEH alone, TCDD (25 mg/kg body weight) alone, DSS+VEH, or a combination
of DSS+TCDD. In DSS mice, TCDD was given as a single dose on the first day of DSS exposure. After seven days, DSS was replaced with a water cycle
(ad libitum) for another seven days. The body weight of the mice was recorded daily. The statistical significance difference between each groups were
assessed by using Mann-Whitney U Test. Data represents the mean of three experiment involving 6 mice per group. There was statistically significant
difference between DSS+VEH vs DSS+TCDD groups (p,0.05). B. Histological sections of colons from the 4 groups of mice, DSS+VEH-treated mice
showed significant lymphocyte infiltration and distortion of glands, while DSS+TCDD-treated mice showed colon lumen having markedly decreased
lymphocyte infiltration. Other pathologic changes during DSS-induced colitis included diffuse leukocyte infiltrates, distorted crypts, and thickening of
the lamina propria in the area of distorted crypts in the colon (B). These changes were significantly reversed in DSS+TCDD groups as seen in
inflammation score (C). Asterisks indicate statistically significant differences; i.e., p,0.01 between DSS+VEH versus DSS+TCDD treated group.
doi:10.1371/journal.pone.0023522.g001
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enhanced in the presence of PTX (Fig. 4F). Together, these data
demonstrated that even in culture conditions that favor Th17
differentiation, TCDD dampens Th17 differentiation while
promoting Treg differentiation. Our data suggested that AhR
ligands might behave differently in as much as FICZ, under
identical culture conditions, promoted Th17 differentiation but
not Tregs differentiation.
AhR plays significant role in TCDD-induced
differentiation of Tregs
To further confirm that the effects of TCDD on Treg induction
was indeed mediated through AhR, we performed in vitro and in
vivo experiments using wild-type C57BL/6 (AhR
+/+) and AhR
knockout (AhR
-/-) mice. To perform in vitro assays, we used T cells
from wild type (AhR
+/+) and AhR knockout (AhR
-/-) mice and
activated them with anti-CD3+CD28 Abs. The cells were also
Figure 2. Effect of TCDD on CD4
+ CXCR3
+ in cells from spleen, MLN and LP and generation of Tregs in the LP following
development of DSS-induced colitis. A–B. Splenic MLN and LP cells were isolated from the four groups of mice as described in Fig 1, stained for
CD4
+ CXCR3
+ T cells, and analyzed using flow cytometry. A representative experiment is shown in panel (A), indicating the percentage of CD4
+
CXCR3
+ T cells, and absolute numbers (mean 6 SEM) of these cells from groups of 6 mice are depicted in panel B. Asterisks (*) indicate statistically
significant differences with p,0.01 between DSS+VEH versus DSS+TCDD treated group. C–D. MLN and LP cells were isolated from the 4 groups of
mice and stained for CD4
+ Foxp3+ cells. A representative experiment is shown in panel C, and absolute numbers (mean 6 SEM) of these cells from
groups of 6 mice are depicted in panel D. Asterisks (*) indicate statistically significant differences (with p,0.01) between VEH versus TCDD alone and
DSS+VEH versus DSS+TCDD treated group.
doi:10.1371/journal.pone.0023522.g002
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harvested on day 3 and analyzed for the expression of Foxp3 and
IL-17 within the CD4
+ T cells. As observed earlier, TCDD
promoted the differentiation of Tregs in AhR
+/+ but not
AhR
-/-mice (Fig. 5A). Also, it was noted that TCDD did not
promote the differentiation of Th17 cells in the culture of T cells
from either of the mice (AhR
+/+ or AhR
-/-; Fig. 5B). Furthermore,
we performed in vivo experiments using wild-type (AhR
+/+) and
AhR knockout (AhR
-/-) mice and treated them either with vehicle
or TCDD. CD4
+ T cells from spleens were examined for the
presence of Tregs or IL-17
+ Th17 cells by flow cytometry. There
was significantly higher percentage and number of Tregs in wild-
type mice treated with TCDD when compared to vehicle-treated
mice (Fig. 5C), similar to that seen using RT-PCR analysis in other
lymphoid organs (Fig 3). In contrast, TCDD failed to induce
significant increase in the percentage and numbers of Tregs in the
knockout (AhR
-/-) mice (Fig. 5C). In these in vivo studies, we
observed minimal number (,2%) of Th17 cells in the presence or
absence of TCDD (Fig. 5D). These data were further corroborated
by the findings of absolute numbers of Tregs and Th17 cells.
Together, these data demonstrated that TCDD-mediated induc-
tion of Tregs was AhR dependent. Also, our in vivo studies
indicated that TCDD could induce Tregs even in naı ¨ve mice in an
AhR-dependent fashion.
TCDD mediates partial demethylation of Foxp3 promoter
and methylation of IL-17 promoter to influence their
regulation
DNA methylation plays an important role in regulation of genes
by silencing their expression. Because under most culture
conditions, TCDD promoted Foxp3 expression, we first evaluated
methylation/ demethylation status of Foxp3 gene promoter, using
in vitro activated T cells from naı ¨ve C57BL/6 mice with anti-
CD3+CD28 Abs in the presence of vehicle or TCDD. To this end,
we performed methylated PCR (MSP) using bisulfite converted
genomic DNA from T cells, using sets of mouse Foxp3-specific
forward and reverse primers that could amplify methylated or
demethylated region of the promoter (Fig. 6A). The data revealed
lower intensity of DNA amplicon of Foxp3 in TCDD-treated T
cells when methylated sets of primers were used when compared to
vehicle controls, whereas the band intensity was significantly
higher when demethylated sets of primers were used (Fig 6A).
Similarly, we used mouse IL-17-specific forward and reverse sets
of primers to amplify methylated or demethylated region of the IL-
17 promoter (Fig. 6B). The data revealed higher intensity of DNA
amplicon of IL-17 in both vehicle- or TCDD-treated T cells when
methylated sets of primers were used but very low intensity
amplicons were observed when primers to amplify demthylated
region were used (Fig. 6B).
To further directly quantitate the methylated/demethylated
status of Foxp3 and IL-17 gene promoters during colitis , we
performed real-time PCR using sets of forward and reverse primers
and Taqman probes and using bisulfite converted genomic DNA
from MLN or LP cells of the following groups of mice: Vehicle
alone,TCDDalone,DSS+vehicle,andDSS+TCDD.MLNand LP
cells from mice treated with DSS+vehicle showed higher level of
methylation (,75%) for Foxp3 promoter (Fig. 6C) but lower levels
of methylation (,25% for MLN and ,30% for LPL) for IL-17
promoter (Fig. 6D) when compared to vehicle-treated control mice
(Fig. 6C). Interestingly, this process was reversed in DSS+TCDD
treated groups when compared to DSS+Veh exposed mice in both
the MLN and LPL cells. Also, analysis of methylation status of
Foxp3 and IL-17 promoters in MLN or LPL cells from mice treated
with TCDD alone when compared to vehicle-treated mice, showed
an overall decreased methylation of Foxp3 and enhanced
methylation of IL-17 promoters. These data supported the
observation that during DSS-induced colitis, hypermethylation of
Foxp3 promoter and hypomethylation of IL-17 promoter may lead
to decreased expression of Foxp3 and increased induction of IL-17.
Furthermore, TCDD treatment may reverse this process thereby
ameliorating the colitis.
Discussion
A large number of environmental chemicals and other
xenobiotics that enter the body mediate their influence on cellular
functions by either nonselective binding to cellular macromole-
cules or specifically binding to cellular receptors. One of these
intracellular chemosensor molecules is the aryl hydrocarbon
receptor (AhR), a transcription factor of the bHLH/PAS family
that is known to regulate the biochemical and toxic effects of
dioxins, polycyclic aromatic hydrocarbons, and structurally related
compounds [37]. Recent studies have identified endogenous
ligands for AhR and suggested that AhR is not only a master
regulator of drug metabolism but also regulates many physiolog-
ical functions such as cell growth and differentiation. More
recently, AhR has been shown to regulate the differentiation of T
cells and therefore play a critical role in the modulation of immune
response. Because environmental chemicals are well known to
Figure 3. Effect of TCDD administration in vivo on Foxp3 and
IL-17 expression in lymphoid organs during colitis. MLN, and LP
cells were isolated on day 14 of colitis from the 4 groups of mice as
described in Fig. 1. RT-PCR was used to detect mRNA levels for Foxp3
and IL-17 (panel A) and data from 3 independent experiments in each
group is shown in panel B. Vertical bars represent mean+/2 SEM of
three independent experiments. Comparisons were made between VEH
vs DSS+VEH groups as well as between DSS+VEH vs DSS+TCDD groups.
Asterisks (*) represent statistically significant (p,0.05) difference
between VEH and DSS+VEH groups and between DSS+VEH and
DSS+TCDD groups.
doi:10.1371/journal.pone.0023522.g003
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studies help establish a link between environmental contaminants
and their ability to alter T cell differentiation through activation of
AhR [39]. In this context, the current study demonstrates, using
TCDD, how AhR activation leads to selective upregulation of
FoxP3
+ Tregs and down regulation of Th17 cells through
epigenetic regulation, leading to amelioration of an inflammatory
disease such as colitis.
In this study, we examined the effect of AhR activation on DSS-
induced colitis in the mouse model. We observed that TCDD
administration reversed DSS-induced colitis in mice. A single dose
of TCDD treatment blocked colitis symptoms, corrected weight
loss, and reduced systemic expression of IL-17, IFN-c, MCP-1,
exotaxin-1, and TNF-a levels. Our results also suggested that the
increase in the number of mucosal CXCR3
+ T cells seen during
acute colitis could be mitigated by TCDD treatment. Moreover,
TCDD elevated Foxp3 expression in the MLN and LP of mice
with colitis. Taken together, these results suggested that TCDD
ameliorates acute colitis by increased generation of Tregs in the
LP of mice with colitis, with consequent decrease in CXCR3
+ T
cell expression.
CXCR3 is express by activated T, epithelial and lymphoid
derived cells. CXCR3 ligands, such as CXCL9 and CXCL10, are
upregulated in many inflammatory diseases and we have reported
that the CXCR3 ligands are upregulated during IBD specifically
[40]. We have also shown that antibody-mediated neutralization
of the CXCR3 ligand CXCL10 inhibits chronic colitis in IL-10
-/-
mice [35]. CXCR3 ligands mainly attract activated T cells of the
Th1 phenotype that express high levels of CXCR3 [41]. In
addition to the pathogenic role played by Th17 cells during colitis
[30], it is also known that colitis may be mediated by cytokine-
producing Th1 cells that infiltrate the mucosa [42]. Such studies
stress the importance of CXCR3 and its ligands in colitis
development [32]. In the present study, we noted reduced
numbers of CXCR3
+ T cells in the spleen, MLN and LP after
TCDD treatment, which may result from direct inhibition of such
Figure 4. Effect of AhR activation by different ligands on reciprocal differentiation of Tregs and Th17 cells in vitro. T cells from naı ¨ve
C57BL/6 mice were activated using anti-mouse CD3 (1 mg/ml) and CD28 (1 mg/ml) mAbs (A, B) or T cells from OTII.2a mice were activated with BMDCs
pulsed with Ova peptide (C, D). The cultures received VEH or TCDD (100 nM/ml) for 72 hrs. In panels E and F, T cells from naı ¨ve C57BL/6 mice were
cultured with BMDCs along with low doses of anti-CD3 Abs (0.5 mg/ml)) and pertusis toxin (PTX), to promote Th17 cells. These cultures also received
VEH, TCDD (100 nM/ml) or FICZ (100 nM/ml) for 72 hrs. The cells were gated for CD4 and analyzed for Foxp3 or IL-17. Data from a representative
histogram and from three independent experiments have been shown. Vertical bars represent mean 6 SEM. In panels A–D, data were compared
between TCDD vs VEH and in panels E and F, PTX groups were compared with PTX+TCDD. Asterisks (*) represent statistically significant (p,0.05)
difference.
doi:10.1371/journal.pone.0023522.g004
Figure 5. TCDD requires AhR to induce reciprocal differentiation of Tregs and Th17 cells in vitro and in vivo. In panels A and B, T cells
from C57BL/6 wild-type (AhR
+/+) and knockout (AhR
-/-) mice were cultured in the presence of anti-mouse CD3 (2 mg/ml) and CD28 (1 mg/ml) mAbs for
72 hrs. These cells were simultaneously treated with VEH or TCDD (100 nM/ml). The cells were stained for Tregs (CD4
+ FoxP-3
+) and Th17 (CD4
+ IL-
17
+) cells. In panels C and D, C57BL/6 wild type (AhR
+/+) and knockout (AhR
-/-) mice were injected with VEH or TCDD and 5 days later, spleen cells
were analyzed for Tregs (CD4
+ FoxP-3
+) and Th17 (CD4
+ IL-17
+) cells. Both percentages and absolute numbers of Tregs and Th17 cells were depicted.
Vertical bars represent data (mean 6 SEM) from three independent experiments. Statistical comparisons were made between TCDD and VEH-treated
groups and asterisks (*) represent statistically significant (p,0.05) differences.
doi:10.1371/journal.pone.0023522.g005
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the amelioration of chronic colitis.
TCDD is well known for its immunosuppressive effects,
specifically causing thymic atrophy and suppression of a wide
range of immune functions [43]. While the ability of TCDD to
cause immunosuppression has been widely reported, the precise
mechanisms have been widely debated. In addition to the direct
effect on the differentiation of Tregs and Th17 cells, AhR
activation may increase prostaglandin E2 production in the colon,
which may lead to amelioration of colitis [44]. It is interesting to
note that AhR-dependent activation of suppressor T cells had
been characterized by one of us as a potential mechanism of
TCDD-induced immunosuppression almost 30 years ago [45,46],
at a time when FoxP3
+ Tregs had not been discovered. In
addition, studies from our laboratory, subsequently, also demon-
strated that TCDD was able to induce apoptosis in activated T
Figure 6. Effect of TCDD on methylation of Foxp3 and IL-17 promoters during colitis. A-B: Phyisical map generated using Methylprimer
Express software (v 1.0) is demonstrating the distribution of CpG islands (vertical red bars) and the position of the MSP primer pairs on the mouse
Foxp3 (A) and Il-17 (B) promoter. PCR amplicons of promoter region of Foxp3 gene amplified by methylated or demethylated sets of primers in T cells
activated in vitro with anti-CD3+anti-CD28 Abs, treated in the presence of VEH or TCDD, has also been depicted in the right panels. C-D: Real Time
PCR demonstrating methylation/demethylation status of Foxp3 and IL-17 promoters in MLN and LPL in vivo. MLNs and LP lymphocytes were isolated
from the four groups of mice as described in Fig 1. Data (mean 6SEM) from 3 independent experiments are shown. Comparisons were made
between VEH vs DSS+VEH groups as well as between DSS+VEH vs DSS+TCDD groups. Asterisks (*) represent statistically significant (p,0.05)
difference between VEH vs DSS+VEH treated groups, and between DSS+VEH vs DSS+TCDD treated groups.
doi:10.1371/journal.pone.0023522.g006
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This stems from the fact that, TCDD can induce the expression of
AhR, Fas and FasL and trigger the extrinsic pathway of apoptosis
in activated T cells [15,16,48]. We also noted that TCDD
regulates Fas and FasL promoters through dioxin responsive
element (DRE) and/or NF-kappaB motifs [48]. While recent
studies have found conflicting results on the induction of Th17 or
Tregs and have attributed this to the affinity of AhR ligands [14],
none of these studies have taken into account the potential role of
TCDD-induced apoptosis in activated T cells, which may
influence the nature of T cells generated and the effector
functions. Thus, clearly additional studies are necessary to
determine if TCDD can selectively induce differential levels of
apoptosis in activated Th17 and Tregs to mediate immunosup-
pressive effects.
The fact that AhR activation leads to suppression of
inflammation has been used recently to demonstrate its efficacy
against some experimental models of inflammation and autoim-
mune disease. For example, TCDD was shown to suppress
diabetes in NOD mice by potentially increasing Foxp3+ T cells in
pancreatic lymph nodes [49]. Also, TCDD inhibited the clinical
symptoms in an experimental autoimmune encephalomyelitis
(EAE) model by inducing Tregs [14]. Interestingly, in the same
study, 6-formylindolo [3,2-b] carbazole (FICZ) interfered with
Treg cell development, and boosted Th17 cell differentiation
thereby increasing the severity of EAE. These findings are
consistent with the current study wherein we noted that while
TCDD increased Tregs and suppressed Th17 cells in culture,
FICZ had opposite effects. These studies suggest that AhR may
regulate both Treg/Th17 differentiation in a ligand-specific
fashion, and therefore the nature of the ligand and the dose may
play a critical role while determining the potential for therapeutic
intervention. It is also likely that different subsets of T cells may
exhibit differential levels of sensitivity to apoptosis following AhR
activation, an aspect that needs to be evaluated further.
Epigenetic modification by CpG methylation at specific sites in
the promoters of various genes present in T cells is getting
increased scrutiny as mechanism of regulation of T cell
differentiation into various subsets [50,51,52]. Both Foxp3 and
IL-17 promoters possess CpG islands in their promoter regions.
Thus, we examined the methylation status of CpG islands present
in Foxp3 and IL-17 promoters following AhR activation. We
selected the promoter regions that carry the maximum number of
CpG islands in Foxp3 and IL-17, to examine their methylation/
demethylation status. As shown in Figure 9, we observed
demethylation of CpG islands present in the Foxp3 promoter
and increased methylation of CpG islands of the IL-17 promoter,
following activation of AhR during colitis. These data suggested
that AhR activation by TCDD may initiate signaling leading to
demethylation or methylation of Foxp3 and IL-17 genes. It has
been reported that demethylation induced by 5-Aza-29-deoxycy-
tidine in human NK cells leads to Foxp3 expression [53]. In
another report, Kim and Leonard demonstrated that 10% to 45%
of the CpG sites in the Foxp3 proximal promoter are methylated
in naive CD4
+CD25
2 T cells, whereas all CpG sites were
demethylated in natural Tregs [54]. They also reported that TGF-
b induced demethylation of CpG in CD4
+CD25
2 T cells [54]. In
another study, it has been shown that CpG regions of Foxp3 is
approximately 70% methylated in CD4
+CD25
lo cells compared
with approximately 5% in CD4
+CD25
hi T cells in humans [55].
These studies demonstrate that methylation of the proximal
promoter is an important regulator of Foxp3 expression. In
another study, it was noted that Th17 cell differentiation was
accompanied by epigenetic changes at IL-17 gene promoter and
suggested that similar to other T helper cell lineages, epigenetic
modification is an integral part of Th17 cell differentiation [56].
They observed hyperacetylation of histone H3 at the IL-17
promoter, and proposed the role of IL-6 and TGF-a ˆ in dictating
epigenetic modification of IL-17 gene [12].
The precise mechanisms through which AhR activation by
TCDD leads to epigenetic regulation is unclear and there are very
few investigations in this area. In one study, the authors tested why
TCDD would induce both CYP1A1 and CYPIB1 in human
MCF-7 cells, while in HepG2 cells, only CYP1A1 was inducible
[57]. They found that the deficiency of CYP1B1 induction in
HepG2 cells was due to cytosine methylation at the promoter CpG
dinucleotides. Thus, treatment of HepG2 cells with the DNA
methyl transferase inhibitor partially demethylated the CpG
dinucleotides in the CYP1B1 gene promoter and restored
TCDD-mediated induction of CYP1B1. In another study, the
effect of postnatal exposure to a reconstituted mixture of AhR
agonists was studied in rats, specifically on DNA methyl
transferases [58]. AhR activation caused reduction in DNA
methyltransferase-1 (Dnmt1) mRNA to 28% and 32% of control,
in the liver and hypothalamus, respectively. Because DNA
methyltransferases are responsible for the generation of genomic
methylation patterns leading to gene silencing, the authors
suggested that early post-natal exposure to environmental
pollutants that act as AhR ligands could cause changes in DNA
methylation thereby impacting gene expression [58].
In summary, our studies suggest that during colitis, activation of
AhR by TCDD may promote anti-inflammatory activity primarily
through epigenetic regulation of Foxp3 and IL-17 gene promoters
leading to preferential differentiation of Tregs and inhibition of
Th17 cells. The Tregs, in turn, may also suppress DSS-induced
Th1 cells and CXCR3
+ T cells to emigrate from MLN to the LP
and inhibit cytokine/chemokine production such as TNF-a,
MCP-1, IL-17, IFN-c and Eotaxin-1, leading to attenuation of
acute colitis.
Materials and Methods
Animals
Female C57BL/6 mice aged 8 to 12 weeks were purchased from
Jackson Laboratories (Bar Harbor, ME).
Ethics Statement
The mice were housed and maintained in micro-isolator cages
under conventional housing conditions at the AAALAC accredited
South Carolina School of Medicine animal facility. Experimental
groups consisted of six mice each and the study was repeated three
times.
Acute colitis induced by DSS and TCDD treatment
Acute colitis was induced using DSS as described elsewhere
[31]. Briefly, eight week-old C57BL/6 mice received either water
or drinking water containing 3% DSS (MP Biomedical, LLC,
Ohio) (ad libitum) for seven days followed by water cycle alone for
seven days. The body weight of mice was monitored every day
from day 0 at the start of TCDD treatment. TCDD was a
generous gift from Dr. Chae (Research Triangle Park NC). TCDD
was dissolved in corn oil and groups of six mice received either
100 mlo f2 5mg/kg body weight single dose of TCDD by intra
peritoneal (i.p.) injection as described [59] or vehicle on the first
day of DSS exposure. At the end of the experiment, blood and
colon samples were collected. The colon was washed with
phosphate-buffered saline, cut longitudinally, formalin fixed, and
paraffin embedded.
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Spleens and mesenteric lymph nodes (MLN) from individual
mice were mechanically dissociated and RBCs were lysed with
lysis buffer (Sigma St. Louis, MO). Single cell suspensions of spleen
and MLN were passed through a sterile wire screen (Sigma St.
Louis, MO). Cell suspensions were washed twice in RPMI 1640
(Sigma St. Louis, MO) and stored in media containing 10% fetal
bovine serum (FBS) on ice until used after one to two hours. The
small intestine/colon was cut into 1-cm stripes and stirred in PBS
containing 1 mM EDTA at 37uC for 30 min. The cells from
intestinal lamina propria (LP) cells were isolated as described
previously [35]. In brief, the LP was isolated by digesting intestinal
tissue with collagenase type IV (Sigma St. Louis, MO) in RPMI
1640 (collagenase solution) for 45 min at 37uC with moderate
stirring. After each 45 min interval, the released cells were
centrifuged, stored in complete medium and mucosal pieces were
replaced with fresh collagenase solution for at least two times. LP
cells were further purified using a discontinuous Percoll (Pharma-
cia, Uppsala, Sweden) gradient collecting at the 40–75% interface.
Lymphocytes were maintained in complete medium, which
consisted of RPMI 1640 supplemented with 10 ml/L of
nonessential amino acids (Mediatech, Washington, DC), 1 mM
sodium pyruvate (Sigma), 10 mM HEPES (Mediatech), 100 U/ml
penicillin, 100 mg/ml streptomycin, 40 mg/ml gentamycin (Elkins-
Sinn, Inc., Cherry Hill, NJ), 50 mM mercaptoethanol (Sigma) and
10 % FCS (Atlanta Biologicals).
Flow cytometry analysis
Cells from the spleen, MLN, and LP were freshly isolated as
described above for each experimental group. For three to four
color FACS cell surface antigens staining, cells were pre-blocked
with Fc receptors for 15 min at 4uC. The cells were washed with
FACS staining buffer (PBS with 1% BSA), and then stained with
CY-, FITC- or PE-conjugated anti-CD4 (H129.19) (BD-PharMin-
gen, San Diego CA), and/or–CXCR3 (CXCR3-173), FoxP3
(FJK-16s) (ebioscience, San Diego CA), for 30 minutes with
occasional shaking at 4uC. The cells were washed twice with
FACS staining buffer and thoroughly re-suspend in BD Cytofix/
Cytoperm (BD-PharMingen, San Diego CA) solution for 20 min.
The cells were again washed twice with BD perm/wash solution
after keeping it for 10 min at 4uC. Lymphocytes were then washed
thoroughly with FACS staining buffer and analyzed by flow
cytometry (FC 500 by Beckman Coulter Fort Collins Co).
Cytokine quantitation by Luminex
TM analysis
T helper cell-derived cytokines, IL-6, IL-17, TNF-a, MCP-1,
IFN-c, and Eotaxin-1 in the serum were determined by a luminex
Elisa assay kit (Millipore Corporation, MA USA). IL-6, TNF-a,
MCP-1, IL-17, IFN-c and Eotaxin-1 analyte beads in assay buffer
were added into pre-wet vacuumed wells followed by 25 mlo f
serum or standard solution, 25 ml of assay buffer, and 25 mlo f
assay beads, and incubated overnight at 4uC with continuous
shaking (at setting #3) using a Lab-Line
TM Instrument Titer Plate
Shaker (Melrose, IL). The filter bottom plates were washed as
before and centrifuged at 300x g for 30 seconds. Subsequently,
25 ml of anti-mouse detection Ab was added to each well and
incubated for 1 hour at room temperature. Next, 25 ml
streptavidin-phycoerythrin solution was added and incubated with
continuous shaking for 30 minute at room temperature. 200 mlo f
wash buffer was added and Milliplex
TM readings were measured
using a Luminex
TM System (Austin, TX) and calculated using
Millipore software. The Ab Milliplex
TM MAP assays were capable
of detecting .10 pg/ml for each analyte.
Histology
Colon was preserved using 10% buffer neutral formalin
followed by 4% paraformaldehyde and embedded in paraffin.
Fixed tissues were sectioned at 6 mm, and stained with hematox-
ylin and eosin for microscopic examination. Intestinal lesions were
multi-focal and of variable severity. Grades were given to intestinal
sections that took into account the number of lesions as well as
severity. A score (0 to 12) was given based on the established
criteria already described [35]. The summation of these scores
provided a total colonic disease score per mouse. The summation
of these disease scores provided a total colonic disease score that
could range from 0 to 12 with grade 1 lesions in proximal, middle
and distal colon segments.
In vitro differentiation of Tregs and Th17 cells in the
presence of TCDD
To determine TCDD-induced differentiation of Tregs and
Th17 cells in vitro, we performed a series of in vitro assays. In brief,
lymphocytes from C57BL/6 mice were cultured in the presence of
purified anti-mouse anti-CD3 (2 mg/ml) and anti-CD28 (1 mg/ml)
mAb for 3 days. These cells were also simultaneously treated with
vehicle (DMSO) or TCDD (100 nM/ml). On day 3, the cells were
further cultured in the presence of PMA (10 ng/ml) and
Ionomycin (1 mg/ml) for 5–6 hrs and in last four hrs of culture,
Golgi stop was added into the culture. The cells were then
harvested, washed twice with PBS, and analyzed for the presence
of Tregs and Th17 cells in the culture. Intracellular staining of
cells was performed using BD Cytofix/Cytosperm kit using their
protocol (BD Biosciences, San Diego, CA). FITC-labeled anti-
mouse CD4 and PE-labeled anti-mouse Foxp3 mAbs were used to
detect Tregs, and FITC-labeled anti-mouse CD4 and PE-labeled
anti-mouse IL-17 mAbs, to detect IL-17 positive Th17 cells.
Differentiation of Tregs and Th17 cells in antigen-specific
activation of T cells was also investigated in the presence or
absence of TCDD. To this end, T cells from OT.II.2a mice were
cultured in the presence of bone marrow-derived dendritic cells
(BMDCs) from C57BL/6 mice. BMDCs were generated as
described earlier [59]. In brief, T cells from OT.II.2a mice were
cultured in the presence of Ova peptide (OvaPep)-pulsed BMDCs
and with vehicle or TCDD for 3 days. Three days post culture, the
cells were harvested and the presence of Tregs and IL-17 positive
Th17 cells in the culture was determined as described above.
TCDD-induced differentiation of Tregs and Th17 cells was also
examined in the absence or presence of Pertussis toxin (PTX), a
culture condition that promotes Th17 differentiation [36]. To this
end, we performed in vitro assays using T cells from C57BL/6 mice
that were cultured in the presence of matured BMDCs from
C57BL/6 mice and CD3 (0.5 mg/ml) Ab for 3 days. These cells
were simultaneously treated with or vehicle or PTX (5 mg/ml),
TCDD (100 nM/ml), TCDD (100 nM/ml) + PTX (5 mg/ml), 6-
formylindolo [3,2-b] carbazole (FICZ) (100 nM/ml), and FICZ
(100 nM/ml) + PTX (1 mg and 5 mg/ml). Three days post culture,
the cells were harvested, washed twice with cold PBS and
intracellular staining was performed as described earlier. Anti-
mouse CD4-FITC and Foxp3-PE mAbs were used to detect Tregs
and anti-mouse CD4-FITC and IL-17-PE mAbs were used to
detect IL-17 positive Th17 cells. The cells were analyzed by flow
cytometry.
Role of AhR in TCDD-induced differentiation of Tregs and
Th17 cells
To investigate the role of AhR in TCDD-induced differentiation
of Tregs and Th17 cells, we used wild type C57BL/6 (AhR
+/+)a n d
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-/-) mice. The mice were injected vehicle or
TCDD intraperitoneally (ip) and on day 6, spleens from treated
mice were harvested, single cell suspension prepared, and the cells
were cultured in the presence of PMA (10 ng/ml) and Ionomycin
(1 mg/ml) for 5–6 hrs and in last four hrs of culture, Golgi stop was
added into the culture. Staining of cells was performed using anti-
mouse CD4-FITC and Foxp3-PE for Tregs, and anti-mouse CD4-
FITC and IL-17-PE for IL-17
+ T cell population. The cells were
later analyzed by flow cytometry.
To further understand the role of AhR in TCDD-induced
differentiation of Tregs and Th17 cells, a series of in vitro assays
were performed. In brief, lymphocytes from C57BL/6 (AhR
+/+)
and AhR
-/- mice were cultured in the presence of anti-CD3
(2 mg/ml) and anti-CD28 (1 mg/ml) Abs for 3 days. These cells
were simultaneously treated with vehicle or TCDD (100 nM/ml).
On day 3, the cells were further cultured in the presence of PMA
(10 ng/ml) and Ionomycin (1 mg/ml) for 5–6 hrs and in last 4 hrs
of culture, Golgi stop was added into the culture. Cells were
harvested, washed twice with cold PBS, and staining of the cells
was performed using anti-mouse CD4-FITC and Foxp3-PE mAbs
for Tregs and anti-mouse CD4-FITC and IL-17-PE for IL-17
+
Th17 cells followed by flow cytometric analysis.
Reverse Transcriptase PCR (RT-PCR) to determine the
expression of Foxp3 and IL-17 in T cells in the presence
or absence of TCDD
First strand cDNA synthesis was performed using total RNA
(1 mg) isolated from T cells cultured in the presence of purified
anti-mouse anti-CD3 and anti-CD28 mAbs as described earlier
and treated with vehicle (DMSO) or TCDD for 3 days using
iScript Kit and following the protocol of the manufacturer (Bio-
Rad). To detect the expression Foxp3 and IL-17, sets of primers
specific to mouse Foxp3 and IL-17 were used. PCR was performed
as described earlier [48]. The PCR products, generated from
mouse Foxp3 and IL-17 primer pairs, were normalized against
PCR products generated from mouse 18S forward (59-GCC-
CGAGCCGCCTGGATAC-39) and reverse (59-CCGGCGGG-
TCATGGGA ATAAC-39) primers after electrophoresis on 1.5%
agarose gel and visualization with UV light. The band intensity of
PCR products was determined using BioRad image analysis
system (BioRad, Hercules, CA).
Detection of methylation in promoters of Foxp3 and IL-
17 genes
We examined methylation/demethylation of Foxp3 and IL-17
gene promoters in T cells in the presence or absence of TCDD or
in various samples harvested from mice exposed to DSS and
treated with vehicle or TCDD. To examine TCDD-induced
regulation of Foxp3 and IL-17 genes, total genomic DNA from T
cells treated with vehicle or TCDD was isolated using DNeasy
Blood & Tissue kit from Qiagen and following the protocol of the
company (Qiagen). Bisulfite modification of total DNA was
performed using Bisulfitization kit from Qiagen. The DNA
concentration was measured using spectrophotometer. Purified
DNA, post bisulfitization, was either used immediately or stored at
220uC for future use.
Methylated PCR
To amplify methylated or demethylated regions of mouse Foxp3
promoter, PCR was performed using mouse bisulfite converted
genomic DNA and mouse Foxp3-specific pair of forward (59-
CGAA GGAGCGGTTTAGTAC-39) and reverse (59-TCTA-
AAACGATTAAAACGCG-39 ) primers to amplify methylated
region or a pair of forward (59-TTTTGAAGGAGTGGTTTAG-
TAT-39 ) and reverse (59-CCATCTAAAACAATTAAAACACA-
39) primers to amplify demethylated region. Similarly, to amplify
methylated or demethylated regions of IL-17 promoter, genomic
PCR analysis was performed using mouse IL-17-specific pair of
forward (59-TTTGATACGGGAAGTTTTTTC-39) and reverse
(59-TACGTAAATCCCCTACGAAAT-39) primers to amplify
methylated region or a pair of forward (59-AAGT TTGATAT-
GGGAAGTTTTTTT-39) and reverse (59-TACATAAATCCC-
CTACAAAATTA-39) primers to amplify demethylated region.
PCR reactions was carried out in a volume of 25 ml containing 1X
EpiTect master mix (EpiTect MSP PCR kit, Qiagen)), bisulfite-
converted DNA (500 ng), and primer pairs (0.3–0.4 mM).
Amplification was performed in a thermal cycler (BioRad) using
the following profile: one step at 95uC for 10 min, three steps
cycling; 45 cycles at 94uC for 15 sec, 58uC for 30 sec, and 72uC
for 45 sec, and one step at 72uC for 10 min. The PCR products,
generated from mouse Foxp3 or IL-17 primer pairs were detected
by electrophoresis using 2% agarose gel and visualization with UV
light. The band intensity of PCR products was determined using
BioRad image analysis system (BioRad).
Real-Time methylated PCR
Real-Time methylated PCRs to detect methylation/demethyl-
ation in the promoters of Foxp3 and IL-17 genes containing CpG
islands were performed using EpiTect MethyLight kit from
Qiagen following the protocol of the company. To this end,
Real-Time PCRs were performed using bisulfite converted
genomic DNA and pairs of mouse Foxp3-specific forward (59-
GGGATTTAGGAGGGGATTT TTT-39) and reverse (59-GA-
AAAATTTTACCTAATACCCACATTTT-39 ) and IL-17-spe-
cific forward (59-GTATAAAGGGTAGATAGATTTGG-39) and
reverse (59-ACATTTAAAACATACAATATTCC CT-39) sets of
primer pairs and TaqMan hybridization probes (methylated
Foxp3 probe: FAM-59-TCGT TTTAGGAGGCGGAGTAGC-
GTTTTT-39, demethylated Foxp3 Probe: Joe-59-TTGTTT-
TAGGAGGT GGTA GTAGTGTTTTT-39, methylated IL-17
probe: FAM-59-TGTTCGTTTTTGCGTAGATATTAG GTC
GTT-39 and demethylated IL-17 probe: Joe-59-TTTGGTGGG-
ATATGTTTGTTTTTGTG T-39). Real-Time methylated PCR
reactions were carried out in a volume of 25 ml using EpiTect
MethyLight master Mix (Qiagen), 500 ng bisulfite converted
genomic DNA, and pairs of forward and reverse primers (100nM)
and TaqMan probes (50 nM). Amplification and detection was
carried out using the following profile: one step at 95uC for 5 min,
and 45 cycles at 95uC for 15 sec and 58uC for 1 min. The
methylation index (%) of each sample was calculated using the
following equation: Methylation index = M/M+U x 100%,
where M is the quantity of methylated and U is the quantity of
demethylated Foxp3 or IL17 real-time MSP following bisulfite
conversion. The samples were categorized as demethylated, low
methylation (1%–50%), or high methylation (51%–100%). All
samples were run in triplicate and the average values were used.
Statistics
The data were expressed as the mean 6 SEM and compared
using a two-tailed paired Student’s t-test or an unpaired Mann
Whitney U test. The results were analyzed using the Statview II
statistical program (Abacus Concepts, Inc., Berkeley, CA) and
Microsoft Excel (Microsoft, Seattle, WA). Single-factor variance
ANOVA analyses were used to evaluate groups. Results were
considered statistically significant if p values were ,0.05 between
the control and the experimental groups.
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Figure S1 TCDD mediated reduction of serum cyto-
kines and chemokines in DSS- induced colitis. Colitis was
induced in mice that were exposed to VEH or 25 mg /kg body
weight of TCDD as described in the legend to Fig 1. Serum
cytokines and chemokines were measured 14 days after the DSS
induction of colitis by ELISA assay. The data presented are the
mean concentrations from 6 mice 6 SEM in serum. Asterisks
indicate statistically significant differences; i.e., p,0.01 between
DSS+VEH versus DSS+TCDD treated group.
(TIF)
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